PL2393476T3 - Kompozycje resweratrolu - Google Patents

Kompozycje resweratrolu

Info

Publication number
PL2393476T3
PL2393476T3 PL10703803T PL10703803T PL2393476T3 PL 2393476 T3 PL2393476 T3 PL 2393476T3 PL 10703803 T PL10703803 T PL 10703803T PL 10703803 T PL10703803 T PL 10703803T PL 2393476 T3 PL2393476 T3 PL 2393476T3
Authority
PL
Poland
Prior art keywords
resveratrol compositions
resveratrol
compositions
Prior art date
Application number
PL10703803T
Other languages
English (en)
Inventor
Sylvain Diguet
Nicolle Götz
Bruno H Leuenberger
Johann Ulm
Loni Schweikert
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of PL2393476T3 publication Critical patent/PL2393476T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
PL10703803T 2009-02-04 2010-02-03 Kompozycje resweratrolu PL2393476T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09152064 2009-02-04
PCT/EP2010/000665 WO2010089104A2 (en) 2009-02-04 2010-02-03 Resveratrol compositions
EP10703803.6A EP2393476B1 (en) 2009-02-04 2010-02-03 Resveratrol compositions

Publications (1)

Publication Number Publication Date
PL2393476T3 true PL2393476T3 (pl) 2016-07-29

Family

ID=42307936

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10703803T PL2393476T3 (pl) 2009-02-04 2010-02-03 Kompozycje resweratrolu

Country Status (8)

Country Link
US (1) US8927046B2 (pl)
EP (1) EP2393476B1 (pl)
JP (1) JP5626809B2 (pl)
KR (1) KR101657326B1 (pl)
CN (1) CN102307568B (pl)
ES (1) ES2567782T3 (pl)
PL (1) PL2393476T3 (pl)
WO (1) WO2010089104A2 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010138584A1 (en) * 2009-05-27 2010-12-02 Cliff Oster Beverage product with resveratrol
EP2755639A2 (de) * 2011-05-30 2014-07-23 2Lution GmbH Feste lösungen von polyphenolen
US9474715B2 (en) * 2011-11-30 2016-10-25 Andreas Voigt Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition
KR102339146B1 (ko) * 2013-05-06 2021-12-15 디에스엠 아이피 어셋츠 비.브이. 분말형 비타민 e 제형
RU2549760C2 (ru) * 2013-05-31 2015-04-27 Михаил Юрьевич Сидоренко Биологически активная добавка и способ ее получения
KR101736098B1 (ko) 2015-04-01 2017-05-17 영남대학교 산학협력단 수용성 레스베라트롤 조성물 및 이의 제조방법
EP3120838A1 (en) 2015-07-20 2017-01-25 Opterion Health AG Aqueous solution comprising a polyphenol
US10722436B2 (en) 2015-08-10 2020-07-28 Mary Kay Inc. Topical compositions
DE102015122672A1 (de) 2015-12-23 2017-06-29 Brauns-Heitmann Gmbh & Co. Kg Pulverförmige Eierfärbemittelzusammensetzung
CN105616357A (zh) * 2016-01-07 2016-06-01 郭敏 一种白藜芦醇干混悬剂及其制备方法
CN105878211B (zh) * 2016-05-31 2019-02-19 肇庆巨元生化有限公司 一种冷水可分散的β-胡萝卜素微囊的制备方法
CN107714670A (zh) * 2016-08-10 2018-02-23 北京万生药业有限责任公司 一种白藜芦醇纳米泡腾片
CA3040307A1 (en) * 2016-10-20 2018-04-26 Grunbiotics Pty Ltd Oral medication formulations
EP3698644A1 (en) 2019-02-20 2020-08-26 Kl-Teho Oy A fishing bait, a mouldable composition for manufacturing the fishing bait, a method for manufacturing the fishing bait and a use of the mouldable composition
US11260025B1 (en) 2021-02-15 2022-03-01 King Abdulaziz University In situ gelling composition as a pH-selective and mucoadhesive sustained release drug delivery system
CN115844954B (zh) * 2022-12-23 2023-07-07 同济大学 一种具有预防口腔疾病的片剂及其制备方法
CN119499226B (zh) * 2025-01-17 2025-05-23 北京市农林科学院 高稳定性及生物可及性白藜芦醇-果胶复合物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
DK546289D0 (da) 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
ITMI20021074A1 (it) * 2002-05-20 2003-11-20 Actimex S R L Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione
CN103211806B (zh) * 2003-05-27 2015-09-09 帝斯曼知识产权资产管理有限公司 新颖的营养药物性组合物及其用途
WO2005000258A1 (en) 2003-06-27 2005-01-06 Amorepacific Corporation Self-assembled polymeric nanoparticles containing physiologically active ingredients and external application containing the nanoparticles
MD2659C2 (ro) 2003-10-29 2005-08-31 Институт Развития Интеллектуальной Собственности Produs biologic activ pulverulent pe bază de vin roşu şi procedeu de obţinere a acestuia
JP4471631B2 (ja) * 2003-11-14 2010-06-02 アサマ化成株式会社 ブドウ由来物のリスベラトロールを用いる飲食品の色調保持方法および飲食品の色調保持剤
JP2008542296A (ja) * 2005-05-25 2008-11-27 サートリス ファーマシューティカルズ， インコーポレイテッド サーチュイン活性化剤による眼障害の処置
ITPD20050224A1 (it) 2005-07-19 2007-01-20 Actimex Srl Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego
ES2546458T3 (es) * 2005-10-21 2015-09-23 Dsm Ip Assets B.V. Nuevas formulaciones de ingredientes activos liposolubles con alta biodisponibilidad
JP5680828B2 (ja) 2006-02-01 2015-03-04 ネステク ソシエテ アノニム 寿命を伸長するための栄養システム及び方法
DE602006013787D1 (de) * 2006-03-28 2010-06-02 Epitech Group Srl Eine Pharmazeutische Zusammensetzung zur Behandlung von Pathologien, die durch die allgemeine Immunantwort verursacht werden
EP2172118A3 (en) 2006-06-13 2011-09-07 IdeaMed LLC Fluid compositions comprising polyphenols and methods for making and packaging the same
CN101292966A (zh) * 2007-04-29 2008-10-29 沈阳皓天万嘉医药科技有限公司 一种白藜芦醇及苷的固体分散体及其制备方法

Also Published As

Publication number Publication date
JP5626809B2 (ja) 2014-11-19
CN102307568B (zh) 2014-12-24
US20120045563A1 (en) 2012-02-23
JP2012516834A (ja) 2012-07-26
EP2393476A2 (en) 2011-12-14
KR101657326B1 (ko) 2016-09-19
ES2567782T3 (es) 2016-04-26
US8927046B2 (en) 2015-01-06
WO2010089104A2 (en) 2010-08-12
KR20110118705A (ko) 2011-10-31
CN102307568A (zh) 2012-01-04
EP2393476B1 (en) 2016-01-13
WO2010089104A3 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
EP2488022A4 (en) Compositions
SMT201600307B (it) Composizione liposomiale
UY33161A (es) Composiciones plaguicidas
PL2393476T3 (pl) Kompozycje resweratrolu
BRPI1013588A2 (pt) composição
DOP2011000396A (es) Composiciones novedosas
BRPI1015474A2 (pt) composição
HRP20181347T1 (hr) Formulacije dvoslojne tablete
DK2640893T4 (da) Sammensætninger
DK2634231T3 (da) Sammensætninger
LT3246021T (lt) Apiksabano kompozicijos
BRPI1010690A2 (pt) composições
BRPI1008774A2 (pt) espiroamida substituída
BRPI1012539A2 (pt) composições farmacêuticas
BRPI1009465A2 (pt) Formulação
IT1394400B1 (it) Composizioni farmaceutiche
BRPI1005919A2 (pt) composição imunogênica
EP2515938A4 (en) IMMUNOGENIC COMPOSITIONS
EP2624836A4 (en) BEPOTASTIN COMPOSITION
BRPI1005318A2 (pt) composição
EP2394634A4 (en) COMPOSITION CONTAINING HESPERIDINE
EP2479211A4 (en) FLUOR RUBBER COMPOSITION
SMT202100150T1 (it) Formulazioni migliorate
BR112012001340A2 (pt) composições farmacêuticas